Controversies in renal artery stenosis: A review by the American Society of Nephrology Advisory Group on hypertension

Adeera Levin, Stuart Linas, Friedrich C. Luft, Arlene B. Chapman, Stephen C Textor

Research output: Contribution to journalArticle

60 Citations (Scopus)

Abstract

Renovascular hypertension is a recognized secondary potentially curable cause of hypertension since the work of Harry Goldblatt. Operative treatments for renal artery stenosis (RAS) have been offered for decades and percutaneous interventions have been widely available for 20 years. Stenting has largely obviated recurrence and modern techniques have contributed greatly to the safety of the procedure. Nevertheless, controversy abounds and prospective randomized trials have not successfully documented the value of intervention in patients with atherosclerotic RAS. The patient population has also changed remarkably. Whereas earlier patients with RAS were identified on clinical grounds, RAS is now commonly found serendipitously during angiography for other reasons. Whether or not these patients benefit from 'drive by' stenting is unknown. The practice may be hazardous and should be critically examined. A dialog and closer cooperation between cardiologists and nephrologists is warranted and organized programs should be formulated to address this problem.

Original languageEnglish (US)
Pages (from-to)212-220
Number of pages9
JournalAmerican Journal of Nephrology
Volume27
Issue number2
DOIs
StatePublished - Apr 2007
Externally publishedYes

Fingerprint

Renal Artery Obstruction
Hypertension
Renovascular Hypertension
Angiography
Safety
Recurrence
Population
Therapeutics

Keywords

  • Ischemic nephropathy
  • Renal artery angioplasty
  • Renal artery stenosis
  • Renal artery stenting
  • Renal vascular disease

ASJC Scopus subject areas

  • Nephrology

Cite this

Controversies in renal artery stenosis : A review by the American Society of Nephrology Advisory Group on hypertension. / Levin, Adeera; Linas, Stuart; Luft, Friedrich C.; Chapman, Arlene B.; Textor, Stephen C.

In: American Journal of Nephrology, Vol. 27, No. 2, 04.2007, p. 212-220.

Research output: Contribution to journalArticle

Levin, Adeera ; Linas, Stuart ; Luft, Friedrich C. ; Chapman, Arlene B. ; Textor, Stephen C. / Controversies in renal artery stenosis : A review by the American Society of Nephrology Advisory Group on hypertension. In: American Journal of Nephrology. 2007 ; Vol. 27, No. 2. pp. 212-220.
@article{195f15a871f545eb8fc4d1e76a4f69e1,
title = "Controversies in renal artery stenosis: A review by the American Society of Nephrology Advisory Group on hypertension",
abstract = "Renovascular hypertension is a recognized secondary potentially curable cause of hypertension since the work of Harry Goldblatt. Operative treatments for renal artery stenosis (RAS) have been offered for decades and percutaneous interventions have been widely available for 20 years. Stenting has largely obviated recurrence and modern techniques have contributed greatly to the safety of the procedure. Nevertheless, controversy abounds and prospective randomized trials have not successfully documented the value of intervention in patients with atherosclerotic RAS. The patient population has also changed remarkably. Whereas earlier patients with RAS were identified on clinical grounds, RAS is now commonly found serendipitously during angiography for other reasons. Whether or not these patients benefit from 'drive by' stenting is unknown. The practice may be hazardous and should be critically examined. A dialog and closer cooperation between cardiologists and nephrologists is warranted and organized programs should be formulated to address this problem.",
keywords = "Ischemic nephropathy, Renal artery angioplasty, Renal artery stenosis, Renal artery stenting, Renal vascular disease",
author = "Adeera Levin and Stuart Linas and Luft, {Friedrich C.} and Chapman, {Arlene B.} and Textor, {Stephen C}",
year = "2007",
month = "4",
doi = "10.1159/000101000",
language = "English (US)",
volume = "27",
pages = "212--220",
journal = "American Journal of Nephrology",
issn = "0250-8095",
publisher = "S. Karger AG",
number = "2",

}

TY - JOUR

T1 - Controversies in renal artery stenosis

T2 - A review by the American Society of Nephrology Advisory Group on hypertension

AU - Levin, Adeera

AU - Linas, Stuart

AU - Luft, Friedrich C.

AU - Chapman, Arlene B.

AU - Textor, Stephen C

PY - 2007/4

Y1 - 2007/4

N2 - Renovascular hypertension is a recognized secondary potentially curable cause of hypertension since the work of Harry Goldblatt. Operative treatments for renal artery stenosis (RAS) have been offered for decades and percutaneous interventions have been widely available for 20 years. Stenting has largely obviated recurrence and modern techniques have contributed greatly to the safety of the procedure. Nevertheless, controversy abounds and prospective randomized trials have not successfully documented the value of intervention in patients with atherosclerotic RAS. The patient population has also changed remarkably. Whereas earlier patients with RAS were identified on clinical grounds, RAS is now commonly found serendipitously during angiography for other reasons. Whether or not these patients benefit from 'drive by' stenting is unknown. The practice may be hazardous and should be critically examined. A dialog and closer cooperation between cardiologists and nephrologists is warranted and organized programs should be formulated to address this problem.

AB - Renovascular hypertension is a recognized secondary potentially curable cause of hypertension since the work of Harry Goldblatt. Operative treatments for renal artery stenosis (RAS) have been offered for decades and percutaneous interventions have been widely available for 20 years. Stenting has largely obviated recurrence and modern techniques have contributed greatly to the safety of the procedure. Nevertheless, controversy abounds and prospective randomized trials have not successfully documented the value of intervention in patients with atherosclerotic RAS. The patient population has also changed remarkably. Whereas earlier patients with RAS were identified on clinical grounds, RAS is now commonly found serendipitously during angiography for other reasons. Whether or not these patients benefit from 'drive by' stenting is unknown. The practice may be hazardous and should be critically examined. A dialog and closer cooperation between cardiologists and nephrologists is warranted and organized programs should be formulated to address this problem.

KW - Ischemic nephropathy

KW - Renal artery angioplasty

KW - Renal artery stenosis

KW - Renal artery stenting

KW - Renal vascular disease

UR - http://www.scopus.com/inward/record.url?scp=34247146390&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34247146390&partnerID=8YFLogxK

U2 - 10.1159/000101000

DO - 10.1159/000101000

M3 - Article

C2 - 17377375

AN - SCOPUS:34247146390

VL - 27

SP - 212

EP - 220

JO - American Journal of Nephrology

JF - American Journal of Nephrology

SN - 0250-8095

IS - 2

ER -